Dyne Therapeutics, Inc. ($DYN)
Friedl-Naderer Johanna โ Chief Commercial Officer
Shares
148
Price
$14.90
Total Value
$2,205.20
Nearby Earnings
Feb 26, 2026
EPS:Est: -0.74
Transaction Details
| Insider | Friedl-Naderer Johanna |
|---|---|
| Title | Chief Commercial Officer |
| Transaction Date | Mar 5, 2026 |
| Transaction Code | S Sale |
| Acquired/Disposed | Disposed |
| Security | Common Stock |
| Direct/Indirect | Direct |
| Filing Date | Mar 6, 2026 |
| Shares Sold | 148 |
| Price per Share | $14.90 |
| Total Value | $2,205.20 |
| Shares Owned After | 154,581 |
| Derivative | No |
| Accession Number | 0001193125-26-096523 |
| Document | View SEC Filing |